Back to Search
PAUL HARARI, MD
MD
Radiation Oncology Physician
NPI: 1902869522IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
31126(WI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Class of 1984
Research & Publications (20)
Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.
PMID 19028347·Semin Radiat Oncol·2009
6-review
The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.
PMID 17848271·Int J Radiat Oncol Biol Phys·2007
8-other
Biology of interactions: antiepidermal growth factor receptor agents.
PMID 17827454·J Clin Oncol·2007
6-review
Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer.
PMID 17848286·Int J Radiat Oncol Biol Phys·2007
8-other
Anti-EGFR therapy update: clinical experience and adverse event insights.
PMID 16736977·Oncology (Williston Park)·2006
8-other
Radiation combined with EGFR signal inhibitors: head and neck cancer focus.
PMID 16378905·Semin Radiat Oncol·2006
6-review
Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
PMID 14967459·Int J Radiat Oncol Biol Phys·2004
6-review
Epidermal growth factor receptor inhibition strategies in oncology.
PMID 15613446·Endocr Relat Cancer·2004
6-review
Searching for reliable epidermal growth factor receptor response predictors: commentary re M. K. Nyati et al., Radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo. Clin. Cancer Res., 10: 691-700, 2004.
PMID 14760061·Clin Cancer Res·2004
6-review
Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.
PMID 12520459·Semin Radiat Oncol·2003
6-review
Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development.
PMID 12174341·Semin Radiat Oncol·2002
6-review
Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
PMID 11173137·Int J Radiat Oncol Biol Phys·2001
7-preclinical
Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling.
PMID 11677653·Semin Radiat Oncol·2001
6-review
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
PMID 19540060·Int J Radiat Oncol Biol Phys·2010
4-observational
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.
PMID 19190133·Clin Cancer Res·2009
7-preclinical
Hidradenomas and a hidradenocarcinoma of the scalp managed using Mohs micrographic surgery and a multidisciplinary approach: case reports and review of the literature.
PMID 19215270·Dermatol Surg·2009
5-case
A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.
PMID 19251098·Int J Radiat Oncol Biol Phys·2009
8-other
Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings.
PMID 19263090·Support Care Cancer·2009
8-other
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab.
PMID 19276677·Cancer Biol Ther·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 263-8500
Quick Facts
- NPI
- 1902869522
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile